Presence of cytokine proteins in those with neuromyelitis optica spectrum disorder was linked to disease activity, which was lessened after treatment with inebilizumab, according to a presentation from ECTRIMS 2023.
“Neuromyelitis optica spectrum disorder is a chronic, autoimmune disease characterized by recurrent attacks on the central nervous system causing permanent neurological damage and cumulative disability,” Sean J. Pittock, MD, director of Mayo Clinic’s Center for Multiple Sclerosis and Autoimmune Neurology, and colleagues wrote. “Cytokine levels are known to